Validation of the cell line LS180 as a model for study of the gastrointestinal toxicity of mycophenolic acid

References

• Allison AC, Eugui EM. (2000). Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85–118
   PubMed Web of Science ®Google Scholar
• Andrikos E, Yavuz A, Bordoni V, et al. (2005). Effect of cyclosporine, mycophenolate mofetil, and their combination with steroids on apoptosis in a human cultured monocytic U937 cell line. Transplant Proc 37:3226–9
   PubMed Web of Science ®Google Scholar
• Arns W. (2007). Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity? Transplant Proc 39:88–93
   PubMed Web of Science ®Google Scholar
• Baggetto LG. (1992). Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74:959–74
   PubMed Web of Science ®Google Scholar
• Brandon EF, Bosch TM, Deenen MJ, et al. (2006). Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. Toxicol Appl Pharmacol 211:1–10
   PubMed Web of Science ®Google Scholar
• Budde K, Glander P, Diekmann F, et al. (2004). Review of the immunosuppressant enteric-coated mycophenolate sodium. Expert Opin Pharmacother 5:1333–45
   PubMed Web of Science ®Google Scholar
• Bullingham RE, Nicholls AJ, Kamm BR. (1998). Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34:429–55
   PubMed Web of Science ®Google Scholar
• Bunnapradist S, Ambuhl PM. (2008). Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies. Clin Transplant 22:815–21
   PubMed Web of Science ®Google Scholar
• Chen WQ, Siegel N, Li L, et al. (2009). Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25. J Proteome Res 8:5285–95
   PubMed Web of Science ®Google Scholar
• Cohn RG, Mirkovich A, Dunlap B, et al. (1999). Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 68:411–18
   PubMed Web of Science ®Google Scholar
• Collett A, Tanianis-Hughes J, Warhurst G. (2004). Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?. Biochem Pharmacol 68:783–90
   PubMed Web of Science ®Google Scholar
• Cummins CL, Mangravite LM, Benet LZ. (2001). Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharm Res 18:1102–9
   PubMed Web of Science ®Google Scholar
• David KM, Morris JA, Steffen BJ, et al. (2005). Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. Clin Transplant 19:279–85
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Rovedatti L, Vidali F, et al. (2013). Recent advances in understanding Crohn's disease. Intern Emerg Med 8:101–13
   PubMed Web of Science ®Google Scholar
• Dubus I, Vendrely B, Christophe I, et al. (2002). Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int 62:857–67
   PubMed Web of Science ®Google Scholar
• Earley EM. (1976). Growth characteristics, cytogenetic stability and virus susceptibility of cell lines from New Zealand rabbits. Dev Biol Stand 37:35–9
   PubMedGoogle Scholar
• Enss ML, Cornberg M, Wagner S, et al. (2000). Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 49:162–9
   PubMed Web of Science ®Google Scholar
• Eugui EM, Allison AC. (1993). Immunosuppressive activity of mycophenolate mofetil. Ann N Y Acad Sci 685:309–29
   PubMed Web of Science ®Google Scholar
• Franklin TJ, Jacobs V, Bruneau P, et al. (1995). Glucuronidation by human colorectal adenocarcinoma cells as a mechanism of resistance to mycophenolic acid. Adv Enzyme Regul 35:91–100
   PubMedGoogle Scholar
• Franklin TJ, Jacobs V, Bruneau P, et al (1996). Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res 56:984–7
   PubMed Web of Science ®Google Scholar
• Forgue-Lafitte ME, Coudray AM, Breant B, et al. (1989). Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. Cancer Res 49:6566–71
   PubMed Web of Science ®Google Scholar
• Gupta A, Mugundu GM, Desai PB, et al. (2008). Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors. Drug Metab Dispos 36:1172–80
   PubMed Web of Science ®Google Scholar
• Gutmann H, Hruz P, Zimmermann C, et al. (2005). Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem Pharmacol 70:695–9
   PubMed Web of Science ®Google Scholar
• Hardinger KL, Brennan DC, Lowell J, et al. (2004). Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 17:609–16
   PubMed Web of Science ®Google Scholar
• Hartley DP, Dai X, Yabut J, et al. (2006). Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines. Pharmacogenet Genomics 16:579–99
   PubMed Web of Science ®Google Scholar
• Hauser IA, Renders L, Radeke HH, et al. (1999). Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 14:58–63
   PubMed Web of Science ®Google Scholar
• Heischmann S, Dzieciatkowska M, Hansen K, et al. (2017). The immunosuppressant mycophenolic acid alters nucleotide and lipid metabolism in an intestinal cell model. Sci Rep 7:45088
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu Z, Huang H, et al. (2005). Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol 5:1029–39
   PubMed Web of Science ®Google Scholar
• Jonsson CA, Carlsten H. (2002). Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages. Cell Immunol 216:93–101
   PubMed Web of Science ®Google Scholar
• Jonsson CA, Carlsten H. (2003). Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells. Int Immunopharmacol 3:31–7
   PubMed Web of Science ®Google Scholar
• Kaczmarek R, Zaczynska E, Misiuk-Hojlo M. (2010). Antiproliferative properties of mycophenolic acid on human retinal pigment epithelial cells in vitro. Klin Oczna 112:201–4
   PubMedGoogle Scholar
• Kauffman HM, Cherikh WS, McBride MA, et al. (2006). Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int 19:607–20
   PubMed Web of Science ®Google Scholar
• van de Kerkhof EG, de Graaf IA, Groothuis GM. (2007). In vitro methods to study intestinal drug metabolism. Curr Drug Metab 8:658–75
   PubMed Web of Science ®Google Scholar
• Lee J, Kim MS, Kim EY, et al. (2008). Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis. Cytokine 44:49–56
   PubMed Web of Science ®Google Scholar
• Lee W, Belkhiri A, Lockhart AC, et al. (2008). Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res 68:10315–23
   PubMed Web of Science ®Google Scholar
• Li Q, Sai Y, Kato Y, et al. (2003). Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines. Pharm Res 20:1119–24
   PubMed Web of Science ®Google Scholar
• Lin T, Meng L, Tsai RY. (2011). GTP depletion synergizes the anti-proliferative activity of chemotherapeutic agents in a cell type-dependent manner. Biochem Biophys Res Commun 414:403–8
   PubMed Web of Science ®Google Scholar
• Meshkini A, Yazdanparast R, Nouri K. (2011). Intracellular GTP level determines cell's fate toward differentiation and apoptosis. Toxicol Appl Pharmacol 253:188–96
   PubMed Web of Science ®Google Scholar
• Messina E, Savini F, Lisio R, et al. (1998). Neuroblastoma cell apoptosis induced by mycophenolic acid. Adv Exp Med Biol 431:461–4
   PubMed Web of Science ®Google Scholar
• Messina E, Gazzaniga P, Micheli V, et al. (2004). Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines. Int J Cancer 108:812–17
   PubMed Web of Science ®Google Scholar
• Peiser C, Riebe-Imre M, Emura M, et al. (1993). Influence of culture passages on growth kinetics, xenobiotic metabolism, chromosomal stability and transformation in a clonal fetal hamster lung epithelial cell line. Mutat Res 289:281–90
   PubMedGoogle Scholar
• Pfrunder A, Gutmann H, Beglinger C, et al. (2003). Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 55:59–66
   PubMed Web of Science ®Google Scholar
• Picard N, Cresteil T, Premaud A, et al. (2004). Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5. Ther Drug Monit 26:600–8
   PubMed Web of Science ®Google Scholar
• Porter AG, Janicke RU. (1999). Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99–104
   PubMed Web of Science ®Google Scholar
• Sabuda-Widemann D, Grabensee B, Schwandt C, et al. (2009). Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells. Nephrol Dial Transplant 24:52–61
   PubMed Web of Science ®Google Scholar
• Shipkova M, Armstrong VW, Wieland E, et al. (1999). Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol 126:1075–82
   PubMed Web of Science ®Google Scholar
• Shipkova M, Strassburg CP, Braun F, et al. (2001). Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol 132:1027–34
   PubMed Web of Science ®Google Scholar
• Shipkova M, Armstrong VW, Weber L, et al. (2002). Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit 24:390–9
   PubMed Web of Science ®Google Scholar
• Shipkova M, Armstrong VW, Oellerich M, et al. (2005). Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability. Expert Opin Drug Metab Toxicol 1:505–26
   PubMedGoogle Scholar
• Watkins RE, Wisely GB, Moore LB, et al. (2001). The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292:2329–33
   PubMed Web of Science ®Google Scholar
• Yalowitz JA, Pankiewicz K, Patterson SE, et al. (2002). Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines. Cancer Lett 181:31–8
   PubMed Web of Science ®Google Scholar
• Young JD, Yao SY, Baldwin JM, et al. (2013). The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Aspects Med 34:529–47
   PubMed Web of Science ®Google Scholar
• Yu H, Cook TJ, Sinko PJ. (1997). Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res 14:757–62
   PubMed Web of Science ®Google Scholar